BioSpace News Archive

NLS Pharmaceutics Ltd. announces that on September 29, 2022, it received a determination letter of the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of the Staff’s determination that, unless the Company timely requests a hearing before a Nasdaq Hearings Panel (the “Panel”), the Company’s securities would be subject to delisting from The Nasdaq Capital Market

Bionix announced its attendance at the American Academy of Pediatrics (AAP) 2022 National Conference & Exhibition in Anaheim, CA , beginning October 7 through October 11, 2022.

BioLink Life Sciences of Cary, North Carolina, today announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the development of Ramatroban for treatment of patients hospitalized with COVID-19 pneumonia (the RAMBAN-1 Study).